International Biophysics Corp has announced that it will now manufacture its medical device AffloVest in the US.
International Biophysics Corp recently announced that the company will now manufacture its AffloVest in the United States. AffloVest is the first portable High Frequency Chest Wall Oscillation (HFCWO) medical device which can provide critical treatment for patients with cystic fibrosis, bronchiectasis, and other respiratory conditions.
In the past, many US companies took their manufacturing facilities abroad, mainly because of tax lower wages and tax advantages. But companies are reconsidering this strategy due to changes in the world economy.
“We manufactured the AffloVest in Germany, but overall costs in Europe, like China, kept rising,” said H. David Shockley Jr, CEO of Austin, Texas-based International Biophysics, in a press release.
Offering a “Made in the USA” brand allows International Biophysics to create a higher-quality product. “By on-shoring our manufacturing, we are creating great jobs domestically, made possible by improved quality and cost competitiveness. We all win,” Shockley said.